Overexpression of β -Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma

Citations of this article
Mendeley users who have this article in their library.


Abnormal expression of β -catenin contributes to tumor development, progression, and metastasis in various cancers. However, little is known about the relationship between abnormal expression of β -catenin and cisplatin chemotherapy in oral squamous cell carcinoma (OSCC). The present study aimed to investigate the effect of β -catenin on OSCC cisplatin resistance and evaluated the drug susceptibility of stable cell lines with β -catenin knockin and knockdown. In this study, we found that higher expression level of β -catenin can be observed in CDDP-treated cell lines as compared with the control group. Furthermore, the expression levels of β -catenin increased in both a concentration- and time-dependent manner with the cisplatin treatment. More importantly, the nuclear translocation of β -catenin could also be observed by confocal microscope analysis. Stable cell lines with CTNNB1 knockin and knockdown were established to further investigate the potential role and mechanism of β -catenin in the chemoresistance of OSCC in vitro and in vivo. Our findings indicated that overexpression of β -catenin promoted cisplatin resistance in OSCC in vitro and in vivo. We confirmed that GSK-3β, C-myc, Bcl-2, P-gp, and MRP-1 were involved in β -catenin-mediated drug resistance. Our findings indicate that the Wnt/ β -catenin signaling pathway may play important roles in cisplatin resistance in OSCC.




Li, L., Liu, H. C., Wang, C., Liu, X., Hu, F. C., Xie, N., … Huang, H. Z. (2016). Overexpression of β -Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma. BioMed Research International, 2016. https://doi.org/10.1155/2016/5378567

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free